Hold everything! Holding policies for protecting plasma supplies

Mathematical Biosciences

Volumn 160, Issue 2, 1999, Pages 159-173

  Kaplan, Edward H ^a   Satten, Glen A ^b  

^a YALE SCHOOL OF MANAGEMENT   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cost benefit analysis; HIV transmission; Holding policy; Plasma donor screening; Renewal theory; Window period

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD STORAGE; COST BENEFIT ANALYSIS; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; TIME;

BLOOD BANKS; BLOOD DONORS; BLOOD-BORNE PATHOGENS; COST-BENEFIT ANALYSIS; HUMANS; MODELS, BIOLOGICAL; MODELS, ORGANIZATIONAL; ORGANIZATION AND ADMINISTRATION; PLASMA;

EID: 0032807719     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(99)00033-4     Document Type: Article

References (11)

1. E.M. Lackritz, G.A. Satten, J. Aberle-Grasse, R.Y. Dodd, V.P. Raimondi, R.S. Janssen, W.F. Lewis, E.P. Notari IV, L.R. Peterson, Estimated risk of transmission of the human immunodeficiency virus by screened blood in the US, New England J. Medicine 333 (1995) 1721.
2. G. A. Satten, Steady-state calculation of the risk of HIV infection from transfusion of screened blood from repeat donors, Math. Biosci. 141 (1997) 101.
3. M.P. Busch, L.L Lee, G.A. Satten, D.R. Henrard, H. Farzadegan, K.E. Nelson, S. Read, R.Y. Dodd, L.R. Petersen, Time course of detection of viral and serological markers preceding HIV-1 seroconversion: implications for blood and tissue donor screening, Transfusion 35 (1995) 91.
4. L.R. Petersen, G.A. Satten, R. Dodd, M. Bush, S. Kleinman, A. Grindon, B. Lenes, J. Karon, the HIV Lookback Study Group: Duration of time from HIV-1 infectiousness to detectable antibody, Transfusion 34 (1994) 283.
5. United States General Accounting Office: Blood Plasma Safety: Plasma Product Risks are Low if Good Manufacturing Practices are Followed. General Accounting Office Report GAO/ HEHS-98-205, United States General Accounting Office, Washington, DC, 1998.
6. J.P. AuBuchon, J.D. Birkmeyer, M.P. Busch, Safety of the blood supply in the United States: opportunities and controversies, Ann. Intern. Medicine 127 (1997) 904.
7. J.P. AuBuchon, J.D. Birkmeyer, M.P. Busch, Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood, Transfusion 37 (1997) 45.
8. J.P. AuBuchon, J.D. Birkmeyer, Safety and cost-effectiveness of solvent-detergent-treated plasma: in search of a zero-risk blood supply, J. Am. Med. Assoc. 272 (1994) 1210.
9. D.R. Cox, Renewal Theory, Methuen, London, 1962.
10. J.P. AuBuchon, personal communication, November 5, 1998.
11. D.K. Owens, personal communication, November 5, 1998.